---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-030137"
form_type: "8-K"
ticker: "FHTX"
cik: "0001822462"
company_name: "Foghorn Therapeutics Inc."
filed_at: "2024-06-26T23:59:59+00:00"
generated_at: "2026-06-01T01:54:16.129767+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Foghorn Therapeutics stockholders re-elect three Class I directors, ratify Deloitte as auditor

## Summary
- Scott Biller elected with 20,425,665 votes for, 4,930,514 against; 5,014,629 broker non-votes.
- Thomas J. Lynch elected with 24,052,377 votes for, 1,293,218 against.
- Michael Mendelsohn elected with 22,357,558 votes for, 2,988,038 against.
- Ratification of Deloitte & Touche as auditor approved: 30,355,319 for, 10,376 against, 15,450 abstentions.

## SEC filing metadata
- accession: 0001628280-24-030137
- form_type: 8-K
- ticker: FHTX
- cik: 0001822462
- company_name: Foghorn Therapeutics Inc.
- filed_at: 2024-06-26T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822462/000162828024030137/0001628280-24-030137-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822462/000162828024030137/fhtx-20240626.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-030137
- JSON: https://secwatch.observer/filing/0001628280-24-030137.json
- Plain text: https://secwatch.observer/filing/0001628280-24-030137.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
